Chengfeng Yi
Overview
Explore the profile of Chengfeng Yi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
4
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zhao S, Tian D, Huang F, Wang L, Cheng J, He Z, et al.
Cancer Cell Int
. 2025 Jan;
25(1):29.
PMID: 39885569
Osteosarcoma (OS) is a commonly observed malignant tumor in orthopedics that has a very poor prognosis. The endosomal sorting complex required for transport (ESCRT) is important for the development and...
2.
Li J, Lan Y, Yi C, Liu Z
Nanoscale
. 2024 Aug;
16(37):17426-17432.
PMID: 39206958
Enhancing the exposure of metal active sites and maximizing metal atom utilization are critical challenges in heterogeneous catalysis. To solve these issues, heterogeneous catalysts are usually activated by chemicals. Herein,...
3.
Yi C, Liu J, Zhao S, Gong D, Xu B, Li A, et al.
Sci Rep
. 2024 Jul;
14(1):16475.
PMID: 39014082
Osteosarcoma (OS) is a heterogeneous malignant spindle cell tumor that is aggressive and has a poor prognosis. Although combining surgery and chemotherapy has significantly improved patient outcomes, the prognosis for...
4.
Liu J, Yi C, Gong D, Zhao Q, Xie H, Zhao S, et al.
Transl Oncol
. 2024 Jul;
47:102047.
PMID: 38972174
Osteosarcoma, one of the most common primary malignancies in children and adolescents, has the primary characteristics of a poor prognosis and high rate of metastasis. This study used super-enhancer-related genes...
5.
Yi C, Li Z, Zhao Q, Gong D, Zhao S, Chen Z, et al.
Biochem Genet
. 2023 Aug;
62(2):1325-1346.
PMID: 37603193
Osteosarcoma (OS) is a malignant bone tumor that most commonly occurs in children and adolescents. OS patients have a poor prognosis, and 5-year survival rates have rarely improved significantly over...
6.
Zhao S, Wang T, Huang F, Zhao Q, Gong D, Liu J, et al.
Biochem Genet
. 2023 Jul;
62(2):831-852.
PMID: 37460861
Osteosarcoma (OS) is a frequent primary malignant bone tumor, with a poor prognosis. Necroptosis is strongly correlated with OS and may be an influential target for treating OS. This study's...
7.
Lan Y, Yi C, Liu Z
Phys Chem Chem Phys
. 2023 Jun;
25(26):17207-17213.
PMID: 37350186
Transition metal and nitrogen co-doped carbon materials (M-N-C) have attracted great attention in the field of catalysis due to their high atomic utilization and outstanding catalytic performance. Herein, a series...
8.
Gong D, Zhao Q, Liu J, Zhao S, Yi C, Lv J, et al.
Front Oncol
. 2023 Jun;
13:1169430.
PMID: 37342196
Osteosarcoma is a primary malignant tumor found mainly in teenagers and young adults. Patients have very little long-term survival. controls tumor initiation and progression by regulating the expression of its...
9.
Zhang L, He Y, Yi C, Huang M
J Healthc Eng
. 2022 Mar;
2022:3208780.
PMID: 35340250
Objective: To evaluate the efficacy of recombinant human endostatin combined with gemcitabine and cisplatin in the treatment of non-small-cell lung cancer (NSCLC). Methods: The databases of Cochrane Library, Embase, ClinicalTrials,...